The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. حسب Zahra Hosseininia (22265113)

Means for STEM competence for pre- and post-test. حسب Esther Kim (2996622)

الموضوعات:

Means for global competence pre- and post-test scores. حسب Esther Kim (2996622)

الموضوعات:

AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. حسب Xiaoqin Li (1399105)

Decadal mean regional hydrology. حسب Nic Gedney (19762301)

الموضوعات:

NSC population and proliferation decrease drastically during the second postnatal week of DG development. حسب Cristina Medina-Menéndez (21800157)

Simulated regional mean wetland seasons. حسب Nic Gedney (19762301)

الموضوعات:

Loss of MAP4K4 expression causes a decrease in the number of neutrophils. حسب Guihua Wang (286390)

Claudin V is decreased following infection with Mtb. حسب Amanda S. Latham (12093638)

"…Exposure to Mtb H37Rv and HN878 decreased claudin V expression compared to uninfected controls in the frontal cortex (E), cerebral nuclei (J), brain stem (O), thalamus (T), and hippocampus (Y). …"

Contemporary mean inundation fraction in the Amazon basin. حسب Nic Gedney (19762301)

الموضوعات:

Regional contemporary (1990–1999 mean) precipitation and JULES inundation fraction over the Amazon basin. حسب Nic Gedney (19762301)

الموضوعات:

Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. حسب Daisuke Sugahara (2047696)

Trends of growth stability index (A), mean productivity index (B), stress tolerance index (C), and harmonic mean (D). حسب Nadia Khater (22553166)

الموضوعات:

Comparison of the albendazole and ivermectin parasitological cure rate (Intention-to-treat). حسب Luccheri Ndong Akomezoghe (18585684)

الموضوعات:

Evolution of the frequency of <i>Loa loa</i> clinical symptoms over the 30-day follow-up period. حسب Luccheri Ndong Akomezoghe (18585684)

الموضوعات:

Eosinophil rate progression by treatment. حسب Luccheri Ndong Akomezoghe (18585684)

الموضوعات:

Descriptive characteristics of the two treatment groups at the inclusion (D0). حسب Luccheri Ndong Akomezoghe (18585684)

الموضوعات:

Evolution of clinical adverse events over the 30-day follow-up period. حسب Luccheri Ndong Akomezoghe (18585684)

الموضوعات:

Comparison of the albendazole and ivermectin parasitological cure rate (Per-protocol). حسب Luccheri Ndong Akomezoghe (18585684)

الموضوعات:

Study flowchart. حسب Luccheri Ndong Akomezoghe (18585684)

الموضوعات: